Form 8-K - Current report:
SEC Accession No. 0001437749-23-009011
Filing Date
2023-04-03
Accepted
2023-04-03 07:00:40
Documents
34
Period of Report
2023-04-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20230401_8k.htm   iXBRL 8-K 25222
2 EXHIBIT 99.1 ex_496129.htm EX-99.1 17244
7 img001.jpg GRAPHIC 5142
8 img02.jpg GRAPHIC 61796
9 img03.jpg GRAPHIC 51480
10 img04.jpg GRAPHIC 52157
11 img05.jpg GRAPHIC 52789
12 img06.jpg GRAPHIC 57924
13 img07.jpg GRAPHIC 40086
14 img08.jpg GRAPHIC 55089
15 img09.jpg GRAPHIC 49472
16 img10.jpg GRAPHIC 61181
17 img11.jpg GRAPHIC 59528
18 img13.jpg GRAPHIC 51139
19 img14.jpg GRAPHIC 70336
20 img15.jpg GRAPHIC 42769
21 img16.jpg GRAPHIC 37072
22 img17.jpg GRAPHIC 49407
23 img18.jpg GRAPHIC 60316
24 img19.jpg GRAPHIC 52191
25 pic1.jpg GRAPHIC 106169
26 pic12.jpg GRAPHIC 90544
  Complete submission text file 0001437749-23-009011.txt   1711881

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20230403.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20230403_def.xml EX-101.DEF 11919
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20230403_lab.xml EX-101.LAB 15966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20230403_pre.xml EX-101.PRE 12130
28 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20230401_8k_htm.xml XML 2649
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 23790575
SIC: 2834 Pharmaceutical Preparations